Clinical Trial Update: Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide [NA]

View source ↗

Summary

A completed clinical trial evaluating neural progenitor cell-sparing radiation therapy in combination with temozolomide for glioblastoma multiforme; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Glioblastoma Multiforme | NA | Status: COMPLETED | Results posted: 2019-06-12